Brief: Empery Asset Management, Lp Transmitted Letter To Management, Board Of Directors Of Seelos Therapeutics, Inc Alleging Material Misrepresentations
Oct 10 (Reuters) - Empery Asset Management, LP:
* EMPERY ASSET MANAGEMENT, LP: TRANSMITTED LETTER TO
MANAGEMENT,
BOARD OF DIRECTORS OF SEELOS THERAPEUTICS, INC ALLEGING MATERIAL
MISREPRESENTATIONS
* EMPERY ASSET MANAGEMENT, LP: FIRMLY BELIEVES SEELOS
KETAMINE
PRODUCT IS AN ASSET
* EMPERY ASSET MANAGEMENT, LP - WITH APPROPRIATE FUNDING AND
A NEW
MANAGEMENT TEAM, EMPERY WOULD BE SUPPORTIVE OF SEELOS
THERAPEUTICS
Source text for Eikon: ID:nBw5WjwHMa
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio